Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Berg

Showing results (261-270 of 632) with videos related to

Pageof 64
Sort By:
Journal of Hepatology|May 12, 2005
Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis CMartin Schaefer, Markus Schwaiger, Andrea S Garkisch, et al.
European Journal of Gastroenterology & Hepatology|August 24, 2010
Serum lipids in European chronic HCV genotype 1 patients during and after treatment with pegylated interferon-α-2a and ribavirinChristian M Lange, Michael von Wagner, Jörg Bojunga, et al.
The Biochemical Journal|March 24, 2004
Intracellular transport of human lysosomal alpha-mannosidase and alpha-mannosidosis-related mutantsGaute Hansen, Thomas Berg, Hilde M F Riise Stensland, et al.
Hepatology (Baltimore, Md.)|July 28, 2006
Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapyFlorian van Bömmel, Bernhard Zöllner, Christoph Sarrazin, et al.
Journal of Microbiological Methods|January 27, 2019
Molecular characterization of intact cell-derived and cell-free bacterial DNA from carious dentine samplesJana Schmidt, Sandra Krohn, Laura Buenger, et al.
Cytokine|March 14, 2008
Evaluation of the transforming growth factor beta1 codon 25 (Arg-->Pro) polymorphism in alcoholic liver diseaseChristoph H Osterreicher, Juliane Halangk, Thomas Berg, et al.
The Journal of Infectious Diseases|February 16, 2020
Erratum to: Repertoire and Neutralizing Activity of Antibodies Against Hepatitis C Virus E2 Peptide in Patients With Spontaneous Resolution of Hepatitis CAnne Olbrich, Hedda Wardemann, Stephan Böhm, et al.
Pathogens (Basel, Switzerland)|December 28, 2021
From Screening to Therapy: Anti-HCV Screening and Linkage to Care in a Network of General Practitioners and a Private Gastroenterology PracticeDavid Petroff, Olaf Bätz, Katrin Jedrysiak, et al.
The Journal of Infectious Diseases|June 6, 2019
Repertoire and Neutralizing Activity of Antibodies Against Hepatitis C Virus E2 Peptide in Patients With Spontaneous Resolution of Hepatitis CAnne Olbrich, Hedda Wardemann, Stephan Böhm, et al.
Scandinavian Journal of Gastroenterology|September 5, 2012
Non-invasive evaluation of hepatic manifestation in Wilson disease with transient elastography, ARFI, and different fibrosis scoresThomas Karlas, Maria Hempel, Michael Tröltzsch, et al.
Pageof 64

Showing results (261-270 of 632) with videos related to

Sort By:
Pageof 64
Journal of Hepatology|May 12, 2005
Prevention of interferon-alpha associated depression in psychiatric risk patients with chronic hepatitis CMartin Schaefer, Markus Schwaiger, Andrea S Garkisch, et al.
European Journal of Gastroenterology & Hepatology|August 24, 2010
Serum lipids in European chronic HCV genotype 1 patients during and after treatment with pegylated interferon-α-2a and ribavirinChristian M Lange, Michael von Wagner, Jörg Bojunga, et al.
The Biochemical Journal|March 24, 2004
Intracellular transport of human lysosomal alpha-mannosidase and alpha-mannosidosis-related mutantsGaute Hansen, Thomas Berg, Hilde M F Riise Stensland, et al.
Hepatology (Baltimore, Md.)|July 28, 2006
Tenofovir for patients with lamivudine-resistant hepatitis B virus (HBV) infection and high HBV DNA level during adefovir therapyFlorian van Bömmel, Bernhard Zöllner, Christoph Sarrazin, et al.
Journal of Microbiological Methods|January 27, 2019
Molecular characterization of intact cell-derived and cell-free bacterial DNA from carious dentine samplesJana Schmidt, Sandra Krohn, Laura Buenger, et al.
Cytokine|March 14, 2008
Evaluation of the transforming growth factor beta1 codon 25 (Arg-->Pro) polymorphism in alcoholic liver diseaseChristoph H Osterreicher, Juliane Halangk, Thomas Berg, et al.
The Journal of Infectious Diseases|February 16, 2020
Erratum to: Repertoire and Neutralizing Activity of Antibodies Against Hepatitis C Virus E2 Peptide in Patients With Spontaneous Resolution of Hepatitis CAnne Olbrich, Hedda Wardemann, Stephan Böhm, et al.
Pathogens (Basel, Switzerland)|December 28, 2021
From Screening to Therapy: Anti-HCV Screening and Linkage to Care in a Network of General Practitioners and a Private Gastroenterology PracticeDavid Petroff, Olaf Bätz, Katrin Jedrysiak, et al.
The Journal of Infectious Diseases|June 6, 2019
Repertoire and Neutralizing Activity of Antibodies Against Hepatitis C Virus E2 Peptide in Patients With Spontaneous Resolution of Hepatitis CAnne Olbrich, Hedda Wardemann, Stephan Böhm, et al.
Scandinavian Journal of Gastroenterology|September 5, 2012
Non-invasive evaluation of hepatic manifestation in Wilson disease with transient elastography, ARFI, and different fibrosis scoresThomas Karlas, Maria Hempel, Michael Tröltzsch, et al.
Pageof 64